Form 4 for HCA HCA Healthcare
Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-05 · accession 0001209191-24-002970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-07 | 2024-02-05 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $82.82 | +8,550 | 16.8K | +104% | +$708.1K |
| D | 2024-02-07 | 2024-02-05 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $310.62 | -4,288 | 14.5K | -23% | -$1.33M |
| DM | 2024-02-07 | 2024-02-05 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $0.00 | -8,550 | 3,040 | -74% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-05 | M | A | 2,510 | $69.58 | 12,760 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-05 | F | D | 4,288 | $310.62 | 14,512 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-05 | M | A | 2,000 | $101.16 | 18,800 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-05 | M | A | 4,040 | $81.96 | 16,800 | D | — | — | |
| 5 | Derivative | Stock Appreciation Right | 2024-02-05 | M | D | 2,510 | $0.00 | 0 | D | $69.58 · — to 2026-01-29 | 2,510 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |
| 6 | Derivative | Stock Appreciation Right | 2024-02-05 | M | D | 4,040 | $0.00 | 0 | D | $81.96 · — to 2027-02-01 | 4,040 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |
| 7 | Derivative | Stock Appreciation Right | 2024-02-05 | M | D | 2,000 | $0.00 | 3,040 | D | $101.16 · — to 2028-01-31 | 2,000 Common Stock | (F3) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |